SPONSOR
Incyte Corporation
Total Trials
4
Recruiting
4
Phases
Phase 3, Phase 1
Conditions studied: NonSegmental VitiligoMyeloproliferative NeoplasmsSolid TumorsAdvanced Solid TumorsMetastatic Solid TumorsRenal Impairment
Incyte Corporation is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including NonSegmental Vitiligo, Myeloproliferative Neoplasms, Solid Tumors, Advanced Solid Tumors.
The trial portfolio spans Phase 3, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Incyte Corporation
How many clinical trials has Incyte Corporation sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Incyte Corporation, of which 4 are actively recruiting participants. These trials cover conditions including NonSegmental Vitiligo, Myeloproliferative Neoplasms, Solid Tumors. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Incyte Corporation research focus on?
Incyte Corporation clinical trials span NonSegmental Vitiligo, Myeloproliferative Neoplasms, Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors, and additional conditions. The research pipeline includes Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Incyte Corporation clinical trial?
To participate in a Incyte Corporation trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Incyte Corporation trials with current recruitment status updated daily.
Clinical Trials by Incyte Corporation
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
NCT05936359 Phase 1
Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Myeloproliferative Neoplasms
NCT05836324 Phase 1
Recruiting
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Solid Tumors
NCT07559396 Phase 1
Recruiting
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
Renal Impairment
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology